Strategic partnership expands access to 'sorely underrepresented' communities across Nevada

By Liza Laws

- Last updated on GMT

© Getty Images
© Getty Images

Related tags IRO Integrated research organization Javara Patient recruitment patient engagement diversity

Sorely underrepresented communities will now be able to access treatments and healthcare options for the first time thanks to a new collaboration.

Javara, an integrated research organization (IRO) that is focused on delivering access to clinical trials at the point of care announced a strategic partnership with Nevada Health Centers (NVHC) yesterday (August 7).

The IRO is going to employ and embed clinical research professionals within NVCH clinics to work alongside physicians and medical staff, providing all aspects of operational collaboration to deliver clinical trials as a care option to their patients.

A Federally Qualified Health Center (FQHC), NVHC is the largest primary care provider for uninsured, underinsured, and geographically isolated Nevadans, with 18 locations and nearly 100 practitioners across the state, spanning Las Vegas, Carson City, Reno, and Elko.

The immediate focus of this new partnership is the Reno and Carson City locations. Javara and NVHC anticipate activation of the first clinical trials in internal medicine in the fall of 2023.

“As an FQHC, many patients served by Nevada Health Centers are from regions and demographic groups that have traditionally been sorely underrepresented in clinical trials,” said Jennifer Byrne, Javara founder and CEO.

“Javara is grateful for the trust of Nevada Health Centers to bring access to novel treatments and innovative health care options to these communities for the first time. With a special focus on those patients with unmet medical needs in geographically isolated and otherwise marginalized regions, we are fully committed to the community benefit this partnership brings.”

Rural communities not previously exposed to research opportunities can now be accessed directly thanks to Javara being able to expand its geographical presence as a result of the collaboration.

As the first-ever clinical research partner to join forces with an FQHC, Javara is eager to deliver clinical research as a care option to patients across Nevada.

Walter Davis, Nevada Health Centers CEO, said: “When seeking a partner to guide Nevada Health Centers’ efforts to develop a clinical trials program for our patients, Javara most closely aligned with our organizational mission and vision.

“We are a safety net provider for the community, and many of our patients live with chronic conditions. This partnership enables us to offer both access to innovative treatments and advanced education to our patients and establish a greater sense of trust in research. We are excited to be positioned as a contributor to the scientific knowledge base that helps improve the delivery and understanding of medicine.”

IRO Javara, partners with large healthcare organizations to deliver clinical trial access at the point of care, reaching patients through their trusted physicians by integrating research staff and infrastructure.

Related topics Patient centricity Consolidation

Related news

Show more

Follow us


View more